{"id":1883,"date":"2023-05-22T09:34:17","date_gmt":"2023-05-22T09:34:17","guid":{"rendered":"https:\/\/innovationisrael.org.il\/en\/?post_type=kol_kore&p=1883"},"modified":"2023-05-24T07:30:46","modified_gmt":"2023-05-24T07:30:46","slug":"koril-strategic-program-bio-convergence-call-for-proposals","status":"publish","type":"kol_kore","link":"https:\/\/innovationisrael.org.il\/en\/kol_kore\/koril-strategic-program-bio-convergence-call-for-proposals\/","title":{"rendered":"KORIL Strategic Program – Bio-Convergence Call for Proposals"},"content":{"rendered":"\n

<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Participating Agencies<\/h2>\n\n\n
\n
\n
Israel Innovation Authority<\/div> <\/div> <\/div>\n
\n
\n
Korea-Israel Industrial R&D Foundation<\/div> <\/div> <\/div>\n <\/div>\n\n\n

Summary<\/h2>\n\n\n\n

Korea Israel Industrial R&D Foundation (KORIL-RDF) is a bi-national foundation, created by the governments of the Republic of Korea and the State of Israel, whose mission is to promote & support technological collaboration in innovative R&D between commercial companies in both countries.<\/p>\n\n\n\n

Relevant Technologies<\/h2>\n\n\n\n

Bio-Convergence fields<\/p>\n\n\n\n

Program Description<\/h2>\n\n\n\n

KORIL-RDF seeks to promote research and development in Korea and Israel by helping Korean-based and Israel-based companies with R&D Partner Search, and Under the Strategic Program of KORIL – providing up to 50% of the R&D expense (in exceptional cases up to 70%) , with the max. grant up to 3M USD in funding for joint R&D projects, in the areas of Bio Convergence. <\/p>\n\n\n\n

Relevant Technologies: <\/strong><\/p>\n\n\n\n

Technological companies in Korea and Israel that are interested in doing join R&D in the following areas in Bio Convergence: <\/p>\n\n\n\n

    \n
  1. Advanced Engineered Drug Delivery & Diagnostics Systems (Bio-nanorobotics)<\/li>\n\n\n\n
  2. Advanced therapeutics discovery systems<\/li>\n\n\n\n
  3. Tissue Engineering \u2013 3D bio-printing & Cyborg tissues<\/li>\n\n\n\n
  4. Bio-electronics & electroceuticals and Bio Sensors & hybrid devices<\/li>\n<\/ol>\n\n\n\n

    * This program is operated under the Authority\u2019s incentive program for Bilateral Funds in Hebrew<\/a> and in English<\/a> as well as on the Israel-Korea Fund (KORIL) website<\/a>.<\/p>\n\n\n\n

    Criteria<\/h2>\n\n\n\n
      \n
    1. Companies from Israel and Korea that are collaborating to develop a joint technological and innovative project in the areas of Bio Convergence are eligible to submit a proposal for grant:\n